Table 6.

Antioxidant activities of 400 mg/kg/day of CVE and IGE in TZM-intoxicated rat cardiac tissue.

Groups	Antioxidant parameters
	GSH	GST	GPx	SOD	CAT	MDA
I	26.8 ± 3.0	31.7 ± 1.1	28.5 ± 2.8	08.4 ± 0.6	44.5 ± 1.2	0.4 ± 0.1
II	35.0 ± 3.6	29.3 ± 0.9	32.5 ± 3.3	07.7 ± 0.5	42.0 ± 6.8	0.5 ± 0.3
III	33.5 ± 4.5	22.9 ± 1.7	24.8 ± 1.8	06.2 ± 0.9	33.4 ± 7.2	0.5 ± 0.1
IV	16.7 ± 2.1c-	19.8 ± 2.2c-	46.9 ± 2.0f+	03.6 ± 0.2c-	17.7 ± 2.4c-	0.8 ± 0.1f+
V	29.5 ± 3.3b+	24.7 ± 0.6b+	19.9 ± 1.1f-	06.5 ± 0.7c+	26.0 ± 2.6b+	0.5 ± 0.1f-
VI	28.3 ± 1.6b+	25.0 ± 0.5b+	19.6 ± 1.8f-	08.1 ± 0.6c+	26.9 ± 1.2b+	0.4 ± 0.1f-
VII	34.8 ± 2.7c+	26.4 ± 0.5c+	16.7 ± 2.1f-	07.6 ± 0.7c+	30.2 ± 2.6c+	0.5 ± 0.1f-

^c- represents a significant decrease at p < 0.0001 when compared to Groups I-III (controls) values while ^f+ represents a significant increases at p < 0.0001 when compared to Groups I-III values; ^b+ and ^c+ represent significant increases at p < 0.05 and p < 0.0001, respectively, when compared to Groups IV values while ^f- represents a significant decrease at p < 0.0001 when compared to untreated positive control (TZM treated only, Group IV).